Skip To Main Content
Xinyi Jiang on Muck Rack

Xinyi Jiang

Charlottesville
As seen in: Business Insider, Business Insider Nordic, Forbes, Wiley Online Library, Aol, Yahoo Finance, Frontiers in Immunology, MarketWatch, MDPI, SFGate and
Darden MBA candidate, former financial journalist at @Mergermarket @Businessinsider, @MedillSchool alumna.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xinyi

Contact Xinyi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Integrated single-cell and experimental analyses implicate GPRC5B in macrophage senescence-related alterations in postmenopausal osteoporosis

|
By Yixin Yang, Jiao Meng, Zhenkun Yang, Xinyi Jiang, Shizhou Zhao
| Frontiers in Immunology
Abstract Background: Post-menopausal osteoporosis (PMO) is characterized by senescence, estrogen deficiency, immune dysregulation and progressive bone loss, yet the molecular alterations involved in PMO remain incompletely understood. Methods: Single-cell and transcriptomic analyses were integrated with machine learning and experimental validation.
Open in Who Shared Issue with article?

Abandonment of Prescribed Buprenorphine for Opioid Use Disorder, 2020-2024

|
By Xinyi Jiang, Kun Zhang, Yijie Chen, Yi-Wen Shih, Nisha Nataraj, Gery P. Guy
| JAMA Network Verified
Supplement 1. eMethods. Buprenorphine Identification Supplement 2. Figure. Trends in First Buprenorphine Prescription Abandonment, January 1, 2020, to September 25, 2024 (opens in new tab) Authors’ analysis of electronic health record–claims linked datasets from Optum Labs Data Warehouse between January 1, 2020, and September 25, 2024.
Open in Who Shared Issue with article?

Endothelial deletion of the neddylation E2 enzyme UBE2M inhibits tumor growth by promoting non-productive angiogenesis

|
By Xinyi Jiang, Jie Zhang, Li Zhou Verified
| The Journal of Clinical Investigation
ResearchCell biologyVascular biology Open Access | 10.1172/JCI201769 J Clin Invest. https://doi.org/10.1172/JCI201769. Copyright © 2026, Jiang et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Abstract Neddylation is highly activated in many human cancers and may serve as a therapeutic target for clinical treatment.
Open in Who Shared Issue with article?
See all 3,706 licensed articles (3,707 Total)